Urinary dengue NS1 detection on Au-decorated ZnO nanowire platform

dc.contributor.authorKannika Sitthisuwannakul
dc.contributor.authorRatchanon Sukthai
dc.contributor.authorZetao Zhu
dc.contributor.authorKazuki Nagashima
dc.contributor.authorKunanon Chattrairat
dc.contributor.authorSupranee Phanthanawiboon
dc.contributor.authorAnnop Klamchuen
dc.contributor.authorSakon Rahong
dc.contributor.authorYoshinobu Baba
dc.contributor.authorTakao Yasui
dc.date.accessioned2025-07-21T06:10:58Z
dc.date.issued2024-03-13
dc.description.abstractBiodetection for non-invasive diagnostics of fluids, especially urine, remains a challenge to scientists due to low target concentrations. And biological complexes of the detection target may contain contaminants that also interfere with any assay. Dengue non-structural 1 protein (Dengue NS1) is an important biomarker for dengue hemorrhagic fever and dengue shock syndrome. Here, we developed an Au-decorated nanowire platform and applied it with a sandwich fluorophore-linked immunosorbent well plate assay (FLISA) to detect Dengue NS1 in urine. For the platform, we fabricated zinc oxide (ZnO) nanowires to provide a high surface area and then coated them with gold nanoparticles (ZnO/Au nanowires) to simply modify the Dengue NS1 antibody and enhance the fluorescence intensity. Our platform employs a sandwich FLISA that exhibits high sensitivity, specifically detecting Dengue NS1 with a limit of detection (LOD) of 1.35 pg/mL. This LOD was 4500-fold lower than the LOD of a commercially available kit for Dengue NS1 enzyme-linked immunosorbent assay. We believe that our ZnO/Au nanowire platform has the potential to revolutionize the field of non-invasive diagnostics for dengue.
dc.identifier.doi10.1016/j.bios.2024.116218
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/13399
dc.subject.classificationMosquito-borne diseases and control
dc.titleUrinary dengue NS1 detection on Au-decorated ZnO nanowire platform
dc.typeArticle

Files

Collections